SG Americas Securities, LLC - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 63 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$321,000
+52.9%
42,463
+174.4%
0.00%
+200.0%
Q2 2019$210,000
+11.7%
15,473
+65.2%
0.00%
-50.0%
Q1 2017$188,0009,3640.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Ground Swell Capital, LLC 25,445$19,0000.05%
ETF MANAGERS GROUP, LLC 2,258,970$1,654,0000.05%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 116,780$85,0000.02%
GSA CAPITAL PARTNERS LLP 131,036$96,0000.01%
Bernardo Wealth Planning LLC 30,469$20,0000.01%
PCG Wealth Advisors, LLC 15,200$12,0000.00%
Penserra Capital Management LLC 212,298$155,0000.00%
ZEKE CAPITAL ADVISORS, LLC 49,700$36,0000.00%
King Wealth Management Group 16,000$12,0000.00%
Vident Investment Advisory, LLC 105,398$77,0000.00%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders